Developer docs
API playgroundTry for free, no card

Search company profiles

Red Cell Partners

Full company profile

uuid00006wd

Namestring
Red Cell Partners
Legal namestring
Red Cell Partners, LLC
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Red Cell Partners is a privately held venture studio founded in 2020 by Grant Verstandig and headquartered in McLean, Virginia, with additional offices in Washington D.C. and Los Angeles. The firm creates, incubates, and scales technology companies across three practice areas — healthcare, cyber, and national security — using a deliberate four-stage process (Discovery, Startup, NewCo, Growth) supported by a six-department internal platform covering HR, legal, finance, product engineering, brand marketing, and operations. As of June 2026, Red Cell has created 15 companies, launched 9 publicly, employs 75 full-time staff, and has helped its incubations reach external capital at an average of 16 months from initial funding, with $497 million raised cumulatively across the firm and portfolio.

The portfolio spans AI-native and deep-tech platforms: Trase (multi-agent AI operating system for regulated industries, with anchor deployment at Duke Health and the U.S. Navy), Claros (chip-to-grid power management for AI data centers, partnered with Samsung Foundry), Andesite (AI-powered bionic SOC for cybersecurity, $38.25M raised), DEFCON AI (AI-driven defense logistics simulation), Zephyr AI (precision medicine with the AIM-Bx and Zephyr Nexus platforms), Crux (employer benefits platform for GLP-1 medications partnered with Ochsner), TARA Mind (mental health therapies including ketamine-assisted treatment), Hunted Labs (open-source software threat hunting), Savoy Life (virtual care for senior living), DeployX (advanced RF communications for military), LightBox (healthcare revenue cycle automation), Sparrow Healthcare (community-based care delivery), and minority stakes in Valinor Enterprises (defense-tech holding company, $85M+ raised) and Evoke Security (AI agent cybersecurity).

Red Cell's revenue model is equity-based rather than transactional: the firm generates returns through ownership stakes in its incubations rather than direct product sales, with operating expenses funded by founder capital, LP commitments, and management economics on capital deployed. Customer end-markets are accessed through portfolio companies across three verticals — healthcare organizations (hospitals, health systems, payers), enterprise and government cybersecurity buyers, and U.S. Department of Defense and intelligence community agencies. The firm's competitive positioning rests on its leadership bench (former NSA Deputy Director George Barnes, former Secretary of Defense Mark T. Esper, former Assistant Secretary of Defense Veronica Daigle, former Navy SEAL David Silverman) and repeat co-investment relationships with tier-1 venture firms including General Catalyst, Bessemer Venture Partners, and ARCH Venture Partners.

Short descriptiontext

Red Cell Partners is a privately held venture studio founded in 2020 and based in McLean, Virginia, that creates and scales technology companies in healthcare, cyber, and national security, with 15 companies created, 9 launched, and $497 million raised across the firm and portfolio as of June 2026.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture studio services, technology incubation, healthcare AI companies, cybersecurity platforms, defense technology startups
Industry2 codes
1Corporate Venture Studios & Incubators (Build/launch ventures)
CodeFSANAHACPrimaryYes
2Corporate Innovation & Technology Scouting Units (with investment mandate)
CodeFSANAHAIPrimaryNo
NAICS code1 code
  • Miscellaneous Intermediation523910
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Venture Studio / Technology Incubation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Equity holdings in portfolio companies
TypeSubscription Recurring
Description

Red Cell generates returns through equity ownership in its incubated and invested companies. The firm has raised $497M across the firm and its incubations, with multiple portfolio companies raising significant external funding rounds.

redcellpartners.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Red Cell Partners is a venture studio that creates, incubates, and scales technology companies in the healthcare, cyber, and national security sectors. The firm identifies market opportunities, recruits founders, provides initial capital, and supplies a cross-functional platform team (HR, legal, finance, product & engineering, brand marketing, operations) to move incubations from idea through independent external funding. Returns are generated through equity ownership in the incubated companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 15 companies created with 9 publicly launched as of June 2026
+2 more records
Product overview1 text field

Red Cell Partners is a venture studio that creates and scales technology companies in healthcare, cyber, and national security sectors. The portfolio comprises multiple distinct platforms: Trase provides a multi-agent AI operating system for healthcare, defense, and energy workflows; Claros offers a chip-to-grid power management platform for data centers; Andesite delivers an AI-powered bionic SOC for cybersecurity; DEFCON AI provides logistics simulation with AI-driven agents; Zephyr AI develops precision medicine tools for drug development; TARA Mind offers mental health therapy benefit programs; Crux operates an employer benefits platform for medications; Hunted Labs provides AI/ML threat hunting; Savoy Life delivers virtual healthcare for senior living; and DeployX pioneers advanced radio-frequency communications. These products range from AI agent platforms and security tools to healthcare benefits and power management solutions, addressing critical infrastructure needs across regulated industries.

Product and service14 records
1Trase
CategoryAI Agent Platform
Description

AI operating system and multi-agent platform for regulated industries (healthcare, defense, energy) that automates complex administrative workflows through autonomous AI agents that coordinate like white blood cells. Replaces manual, repetitive processes with secure, audit-ready agents and has demonstrated 7.1x faster fax triage at Duke Health.

2Claros
CategoryData Center Power Management
Description

Chip-to-grid power management platform for data centers that innovates at the intersection of power and compute. Features integrated voltage regulators (IVR) and DC-native Power Gateway to reduce energy waste from AI workloads, in strategic manufacturing collaboration with Samsung Foundry.

3Andesite Bionic SOC
CategoryCybersecurity Platform
Description

AI-powered bionic Security Operations Center (SOC) platform enabling collaboration between human analysts and AI. Connects siloed data across security ecosystems to accelerate threat detection, investigation, and response, and helps teams shift from reactive alert triage to proactive threat hunting.

4Crux
CategoryHealthcare Benefits Platform
Description

No-fee employer benefits platform partnering with pharmaceutical companies to expand affordable access to quality-of-life medications, starting with GLP-1s for obesity management.

5DEFCON AI
CategoryDefense Logistics Simulation
Description

Decision-support and logistics simulation platform using AI-driven intelligent agents for military logistics planning. The Artiv platform merges next-generation modeling and simulation with intelligent agents to deliver operational wargaming analysis in minutes for contested mobility scenarios.

6Zephyr AI
CategoryPrecision Medicine AI
Description

Precision medicine company developing AI-enabled tools (AIM-Bx for drug response prediction and Zephyr Nexus for real-world insights) operating on large-scale real-world clinico-genomic data to accelerate drug development and improve outcomes in oncology and cardiometabolic disease.

7TARA Mind
CategoryMental Health Therapy Benefits
Description

Health-tech company building innovative benefit programs for mental health therapies through a national provider network and collaborative care platform, offering ketamine-assisted therapy access for treatment-resistant depression.

8Hunted Labs
CategorySoftware Supply Chain Security
Description

AI/ML-powered threat hunting and unified threat management platform for the software development lifecycle, providing visibility across open source software ecosystems to identify and remediate malicious threats and reduce remediation time.

9Savoy Life
CategorySenior Virtual Healthcare
Description

Virtual healthcare solution platform bringing health and compliance support services to the long-term care industry, helping adult family homes and assisted living communities close healthcare gaps and improve quality of life for seniors.

10DeployX
CategoryDefense Communications Technology
Description

Advanced communications company pioneering integrated radio-frequency technologies for mission-critical operations, delivering secure, reliable long-range communications for military connectivity with critical assets and distributed forces.

11Valinor Enterprises
CategoryDefense Tech Holding Company
Description

Operational holding company for defense and government technology using a hub-and-spoke model, with multiple Product Companies covering military construction, munition lifecycle management, maritime support, mobile medical systems, smart optics, and unmanned aircraft systems. Has partnerships with Anduril and Palantir.

12Evoke Security
CategoryAI Agent Security
Description

Cybersecurity platform providing visibility and control over AI agents accessing sensitive corporate data and systems, addressing enterprise security gaps for autonomous AI agents in production environments.

13LightBox
CategoryHealthcare Revenue Cycle Intelligence
Description

AI-powered revenue cycle intelligence and automation platform for healthcare providers.

14Sparrow Healthcare
CategoryCommunity Healthcare Delivery
Description

Trusted community-based healthcare delivery platform providing care that starts in local communities.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-16
Description

Strategic manufacturing collaboration with Samsung Foundry to produce integrated voltage regulators for AI data centers, supporting Claros' chip-to-grid power management solutions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-07
Description

Partnership with Crux to launch obesity management medicine benefits platform for employers nationwide.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-15
Description

Trase's AI agents are available on Google Cloud Marketplace, enabling organizations to deploy Trase's multi-agent systems for enterprise productivity.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-30
Description

Duke Health partnered with Trase to develop AI healthcare tools, deploying autonomous AI agents for healthcare workflows including fax triage and administrative process automation. Initial results showed 7.1x faster processing and significant time savings.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-26
Description

Zephyr AI acquired Aster Insights (formerly M2Gen) to expand its clinicogenomic data resources and accelerate precision medicine algorithms.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Strategic collaboration to advance AI in healthcare, supporting Red Cell's healthcare practice and portfolio companies.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Valinor has partnered with Anduril to build and acquire critical defense technology solutions.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Valinor has partnered with Palantir as part of its defense tech ecosystem strategy.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The CIA's strategic not-for-profit investor that identifies, funds, and accelerates technology companies for the U.S. intelligence community. Most directly comparable to Red Cell's cyber and national security practice, including the same mission-aligned approach and government customer focus.

TypeDirect peer
Description

Flagship co-investor across multiple Red Cell portfolio companies (Andesite, Claros, Valinor). A late-stage VC increasingly building company-creation capabilities (e.g., GC Institute) that overlap with Red Cell's studio model, especially in healthcare and national security.

TypeDirect peer
Description

Led Trase's $107M seed round in 2026 and is a long-tenured deep-tech/healthcare investor that also actively creates and spins out companies from academic research. Comparable to Red Cell in its willingness to incubate breakthrough science in regulated industries.

TypeDirect peer
Description

Lead investor in DEFCON AI's seed and a co-investor across Red Cell's portfolio. A multi-stage firm with deep defense-tech and healthcare exposure that increasingly partners with — and sometimes competes with — studio-style origination models.

TypeBroad incumbent
Description

A leading defense-tech prime that Valinor has explicitly partnered with. Operates broadly across defense and national security with overlapping interest in autonomous systems, comms, and counter-drone — the same verticals where Red Cell's DeployX and DEFCON AI operate.

TypeBroad incumbent
Description

A defense/cyber and data analytics incumbent that Valinor partners with. Comparable to Red Cell's defense and cyber practices in its government buyer relationships and AI-driven mission software, though it is a much larger, public company.

TypeBroad incumbent
Description

A large defense and intelligence consulting firm with deep government relationships and AI practice that overlaps with Red Cell's national security and cyber practices. Serves the same federal buyer base though at significantly greater scale and breadth.

TypeDirect peer
Description

A nonprofit research institute that creates and spins out technology companies in healthcare, cyber, and national security. Conceptually very close to Red Cell's studio model, combining R&D with company creation, though structured as a non-profit.

TypeDirect peer
Description

A deep-tech investor that actively incubates companies at the intersection of science, technology, and government/dual-use applications. Comparable in its willingness to back hard-tech and national-security bets and in building concentrated founder networks.

TypeDirect peer
Description

A closely held private investment bank with a founder-led, relationship-driven model similar to Red Cell's approach. Comparable in scale, discretion, and focus on long-duration capital partnerships rather than traditional fund structures.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries15 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment20 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Red Cell Partners

Venture Studio / Technology Incubationredcellpartners.com

Red Cell Partners is a privately held venture studio founded in 2020 and based in McLean, Virginia, that creates and scales technology companies in healthcare, cyber, and national security, with 15 companies created, 9 launched, and $497 million raised across the firm and portfolio as of June 2026.

What Red Cell Partners does

Red Cell Partners is a privately held venture studio founded in 2020 by Grant Verstandig and headquartered in McLean, Virginia, with additional offices in Washington D.C. and Los Angeles. The firm creates, incubates, and scales technology companies across three practice areas — healthcare, cyber, and national security — using a deliberate four-stage process (Discovery, Startup, NewCo, Growth) supported by a six-department internal platform covering HR, legal, finance, product engineering, brand marketing, and operations. As of June 2026, Red Cell has created 15 companies, launched 9 publicly, employs 75 full-time staff, and has helped its incubations reach external capital at an average of 16 months from initial funding, with $497 million raised cumulatively across the firm and portfolio.

The portfolio spans AI-native and deep-tech platforms: Trase (multi-agent AI operating system for regulated industries, with anchor deployment at Duke Health and the U.S. Navy), Claros (chip-to-grid power management for AI data centers, partnered with Samsung Foundry), Andesite (AI-powered bionic SOC for cybersecurity, $38.25M raised), DEFCON AI (AI-driven defense logistics simulation), Zephyr AI (precision medicine with the AIM-Bx and Zephyr Nexus platforms), Crux (employer benefits platform for GLP-1 medications partnered with Ochsner), TARA Mind (mental health therapies including ketamine-assisted treatment), Hunted Labs (open-source software threat hunting), Savoy Life (virtual care for senior living), DeployX (advanced RF communications for military), LightBox (healthcare revenue cycle automation), Sparrow Healthcare (community-based care delivery), and minority stakes in Valinor Enterprises (defense-tech holding company, $85M+ raised) and Evoke Security (AI agent cybersecurity).

Red Cell's revenue model is equity-based rather than transactional: the firm generates returns through ownership stakes in its incubations rather than direct product sales, with operating expenses funded by founder capital, LP commitments, and management economics on capital deployed. Customer end-markets are accessed through portfolio companies across three verticals — healthcare organizations (hospitals, health systems, payers), enterprise and government cybersecurity buyers, and U.S. Department of Defense and intelligence community agencies. The firm's competitive positioning rests on its leadership bench (former NSA Deputy Director George Barnes, former Secretary of Defense Mark T. Esper, former Assistant Secretary of Defense Veronica Daigle, former Navy SEAL David Silverman) and repeat co-investment relationships with tier-1 venture firms including General Catalyst, Bessemer Venture Partners, and ARCH Venture Partners.

Red Cell Partners firmographics

Firmographics
Name
Red Cell Partners
Legal name
Red Cell Partners, LLC
Website
https://redcellpartners.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Short description
Red Cell Partners is a privately held venture studio founded in 2020 and based in McLean, Virginia, that creates and scales technology companies in healthcare, cyber, and national security, with 15 companies created, 9 launched, and $497 million raised across the firm and portfolio as of June 2026.
Ownership category
akta.pro rank

Red Cell Partners industry classification

Industry
Product category
Venture Studio / Technology Incubation
NAICS
Miscellaneous Intermediation (523910)
SIC
Services-Management Consulting Services (8742)
akta.pro primary industry
Corporate Venture Studios & Incubators (Build/launch ventures) (FSANAHAC)
akta.pro secondary industry
Corporate Innovation & Technology Scouting Units (with investment mandate) (FSANAHAI)

Keywords

  • Venture studio services
  • Technology incubation
  • Healthcare AI companies
  • Cybersecurity platforms
  • Defense technology startups

Where Red Cell Partners is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Red Cell Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Equity holdings in portfolio companies: Red Cell generates returns through equity ownership in its incubated and invested companies. The firm has raised $497M across the firm and its incubations, with multiple portfolio companies raising significant external funding rounds.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Red Cell Partners product offering

Product offering

Core offering

Red Cell Partners is a venture studio that creates, incubates, and scales technology companies in the healthcare, cyber, and national security sectors. The firm identifies market opportunities, recruits founders, provides initial capital, and supplies a cross-functional platform team (HR, legal, finance, product & engineering, brand marketing, operations) to move incubations from idea through independent external funding. Returns are generated through equity ownership in the incubated companies.

Product overview

Red Cell Partners is a venture studio that creates and scales technology companies in healthcare, cyber, and national security sectors. The portfolio comprises multiple distinct platforms: Trase provides a multi-agent AI operating system for healthcare, defense, and energy workflows; Claros offers a chip-to-grid power management platform for data centers; Andesite delivers an AI-powered bionic SOC for cybersecurity; DEFCON AI provides logistics simulation with AI-driven agents; Zephyr AI develops precision medicine tools for drug development; TARA Mind offers mental health therapy benefit programs; Crux operates an employer benefits platform for medications; Hunted Labs provides AI/ML threat hunting; Savoy Life delivers virtual healthcare for senior living; and DeployX pioneers advanced radio-frequency communications. These products range from AI agent platforms and security tools to healthcare benefits and power management solutions, addressing critical infrastructure needs across regulated industries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Trase AI operating system and multi-agent platform for regulated industries (healthcare, defense, energy) that automates complex administrative workflows through autonomous AI agents that coordinate like white blood cells. Replaces manual, repetitive processes with secure, audit-ready agents and has demonstrated 7.1x faster fax triage at Duke Health.
  • Claros Chip-to-grid power management platform for data centers that innovates at the intersection of power and compute. Features integrated voltage regulators (IVR) and DC-native Power Gateway to reduce energy waste from AI workloads, in strategic manufacturing collaboration with Samsung Foundry.
  • Andesite Bionic SOC AI-powered bionic Security Operations Center (SOC) platform enabling collaboration between human analysts and AI. Connects siloed data across security ecosystems to accelerate threat detection, investigation, and response, and helps teams shift from reactive alert triage to proactive threat hunting.
  • Crux No-fee employer benefits platform partnering with pharmaceutical companies to expand affordable access to quality-of-life medications, starting with GLP-1s for obesity management.
  • DEFCON AI Decision-support and logistics simulation platform using AI-driven intelligent agents for military logistics planning. The Artiv platform merges next-generation modeling and simulation with intelligent agents to deliver operational wargaming analysis in minutes for contested mobility scenarios.
  • Zephyr AI Precision medicine company developing AI-enabled tools (AIM-Bx for drug response prediction and Zephyr Nexus for real-world insights) operating on large-scale real-world clinico-genomic data to accelerate drug development and improve outcomes in oncology and cardiometabolic disease.
  • TARA Mind Health-tech company building innovative benefit programs for mental health therapies through a national provider network and collaborative care platform, offering ketamine-assisted therapy access for treatment-resistant depression.
  • Hunted Labs AI/ML-powered threat hunting and unified threat management platform for the software development lifecycle, providing visibility across open source software ecosystems to identify and remediate malicious threats and reduce remediation time.
  • Savoy Life Virtual healthcare solution platform bringing health and compliance support services to the long-term care industry, helping adult family homes and assisted living communities close healthcare gaps and improve quality of life for seniors.
  • DeployX Advanced communications company pioneering integrated radio-frequency technologies for mission-critical operations, delivering secure, reliable long-range communications for military connectivity with critical assets and distributed forces.
  • Valinor Enterprises Operational holding company for defense and government technology using a hub-and-spoke model, with multiple Product Companies covering military construction, munition lifecycle management, maritime support, mobile medical systems, smart optics, and unmanned aircraft systems. Has partnerships with Anduril and Palantir.
  • Evoke Security Cybersecurity platform providing visibility and control over AI agents accessing sensitive corporate data and systems, addressing enterprise security gaps for autonomous AI agents in production environments.
  • LightBox AI-powered revenue cycle intelligence and automation platform for healthcare providers.
  • Sparrow Healthcare Trusted community-based healthcare delivery platform providing care that starts in local communities.

Quantifiable outcome

  • 15 companies created with 9 publicly launched as of June 2026
  • +2 more outcomes

Companies that use Red Cell Partners

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Red Cell Partners technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability9 records

Feature2 records

Red Cell Partners partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Samsung FoundrycoreStrategic or Co-development Partner · 16 June 2026Strategic manufacturing collaboration with Samsung Foundry to produce integrated voltage regulators for AI data centers, supporting Claros' chip-to-grid power management solutions.
  • Ochsner Connected HealthcoreStrategic or Co-development Partner · 7 January 2026Partnership with Crux to launch obesity management medicine benefits platform for employers nationwide.
  • Google CloudcoreTechnology or Integration · 15 December 2025Trase's AI agents are available on Google Cloud Marketplace, enabling organizations to deploy Trase's multi-agent systems for enterprise productivity.
  • Duke HealthcoreStrategic or Co-development Partner · 30 September 2025Duke Health partnered with Trase to develop AI healthcare tools, deploying autonomous AI agents for healthcare workflows including fax triage and administrative process automation. Initial results showed 7.1x faster processing and significant time savings.
  • Aster InsightscoreStrategic or Co-development Partner · 26 August 2025Zephyr AI acquired Aster Insights (formerly M2Gen) to expand its clinicogenomic data resources and accelerate precision medicine algorithms.
  • UMass Chan Medical SchoolcoreStrategic or Co-development Partner · 1 January 2025Strategic collaboration to advance AI in healthcare, supporting Red Cell's healthcare practice and portfolio companies.
  • AndurilminorStrategic or Co-development Partner · 1 January 2025Valinor has partnered with Anduril to build and acquire critical defense technology solutions.
  • PalantirminorStrategic or Co-development Partner · 1 January 2025Valinor has partnered with Palantir as part of its defense tech ecosystem strategy.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Red Cell Partners competitors and assessment

Company assessment

Direct peers

  • In-Q-Tel: The CIA's strategic not-for-profit investor that identifies, funds, and accelerates technology companies for the U.S. intelligence community. Most directly comparable to Red Cell's cyber and national security practice, including the same mission-aligned approach and government customer focus.
  • General Catalyst: Flagship co-investor across multiple Red Cell portfolio companies (Andesite, Claros, Valinor). A late-stage VC increasingly building company-creation capabilities (e.g., GC Institute) that overlap with Red Cell's studio model, especially in healthcare and national security.
  • ARCH Venture Partners: Led Trase's $107M seed round in 2026 and is a long-tenured deep-tech/healthcare investor that also actively creates and spins out companies from academic research. Comparable to Red Cell in its willingness to incubate breakthrough science in regulated industries.
  • Bessemer Venture Partners: Lead investor in DEFCON AI's seed and a co-investor across Red Cell's portfolio. A multi-stage firm with deep defense-tech and healthcare exposure that increasingly partners with — and sometimes competes with — studio-style origination models.
  • SRI International: A nonprofit research institute that creates and spins out technology companies in healthcare, cyber, and national security. Conceptually very close to Red Cell's studio model, combining R&D with company creation, though structured as a non-profit.
  • Lux Capital: A deep-tech investor that actively incubates companies at the intersection of science, technology, and government/dual-use applications. Comparable in its willingness to back hard-tech and national-security bets and in building concentrated founder networks.
  • Allen & Company: A closely held private investment bank with a founder-led, relationship-driven model similar to Red Cell's approach. Comparable in scale, discretion, and focus on long-duration capital partnerships rather than traditional fund structures.

Broad incumbents

  • Anduril Industries: A leading defense-tech prime that Valinor has explicitly partnered with. Operates broadly across defense and national security with overlapping interest in autonomous systems, comms, and counter-drone — the same verticals where Red Cell's DeployX and DEFCON AI operate.
  • Palantir Technologies: A defense/cyber and data analytics incumbent that Valinor partners with. Comparable to Red Cell's defense and cyber practices in its government buyer relationships and AI-driven mission software, though it is a much larger, public company.
  • Booz Allen Hamilton: A large defense and intelligence consulting firm with deep government relationships and AI practice that overlaps with Red Cell's national security and cyber practices. Serves the same federal buyer base though at significantly greater scale and breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Red Cell Partners social profiles

Digital presence

Red Cell Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Red Cell Partners leadership team

Management profile

Number of profiles

Profiles17 records

Red Cell Partners subsidiaries and ownership

Company hierarchy

Subsidiaries15 records

Red Cell Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Red Cell Partners M&A and investment

M&A and investment

M&A

Investments20 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Red Cell Partners

What does Red Cell Partners do?

Red Cell Partners is a venture studio that creates, incubates, and scales technology companies in the healthcare, cyber, and national security sectors. The firm identifies market opportunities, recruits founders, provides initial capital, and supplies a cross-functional platform team (HR, legal, finance, product & engineering, brand marketing, operations) to move incubations from idea through independent external funding. Returns are generated through equity ownership in the incubated companies.

Is Red Cell Partners a public or private company?

Red Cell Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Red Cell Partners founded?

Red Cell Partners was founded in 2020. It employs 51 to 100 people.

Where is Red Cell Partners based?

Red Cell Partners is headquartered in Washington, United States, in the North America region.

How does Red Cell Partners make money?

One revenue line is on record: equity holdings in portfolio companies.

Who are Red Cell Partners's main competitors?

Direct peers on record are In-Q-Tel, General Catalyst, ARCH Venture Partners, Bessemer Venture Partners, SRI International, Lux Capital and Allen & Company. Broad incumbents are Anduril Industries, Palantir Technologies and Booz Allen Hamilton.

Does Red Cell Partners have an API?

No public API is recorded for Red Cell Partners.

What industry is Red Cell Partners in?

Red Cell Partners's product category is Venture Studio / Technology Incubation. Its primary akta.pro industry code is FSANAHAC, Corporate Venture Studios & Incubators (Build/launch ventures), with a secondary code of FSANAHAI, Corporate Innovation & Technology Scouting Units (with investment mandate). Its NAICS code is 523910 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsRed Cell Partners wins Pentagon cost-saving contractRed Cell Partners, a startup investment and incubation firm, won a Pentagon contract that could generate $100 million for its portfolio startups. The deal comes as the Pentagon increasingly turns to startups.Business Wire BlogCDAO Awards Red Cell Partners $100M Agreement to Pilot Shared SavingsCDAO awarded Red Cell Partners a one-year agreement with a $100M ceiling to pilot shared savings, paying only for verified outcomes. The framework, structured as Other Transaction Authority, aims to reduce costs on existing contracts and fund warfighter readiness. Similar models have generated $19.3B in federal energy savings.Washington TechnologySupply chain, operations and health leadership moves across the marketMultiple supply chain, operations, and health leadership roles were filled across defense and technology firms, including Aeon, BAE Systems, Blackwatch, and BWX Technologies. The moves include new vice presidents and chief data officers, with some roles created or expanded. Board appointments also occurred at Air and Veilant.AxiosGlenn Youngkin's private sector return: VC editionGlenn Youngkin is returning to the private sector, joining venture studio Red Cell Partners as partner, chairman, and board member. He will focus on LP relationships, government relations, and business partnerships, with the role taking 1-2 days a week. Red Cell is raising a second fund that has already surpassed its first fund's $91.2 million.MorningstarGlenn Youngkin, 74th Governor of Virginia and former Carlyle Co-CEO, Joins Red Cell Partners as ChairmanGlenn Youngkin, 74th Governor of Virginia and former Carlyle Co-CEO, joined Red Cell Partners as chairman and board member. Red Cell, founded in 2020, builds national security, cyber, and healthcare technology companies. Youngkin cited recent successes like Trase, Claros, and Hunted Labs.American City Business JournalsRed Cell Partners launches MyPattern, a women's health platformRed Cell Partners launched MyPattern, a direct-to-consumer women's health platform aimed at helping women manage their health and prepare for medical appointments. This marks the venture capital firm's first direct-to-consumer offering in this sector.FinSMEsTrase Raises $107M in Seed FundingTrase, a developer of an agentic operating system for high-stakes environments, raised $107M in seed funding led by ARCH Venture Partners. The company will use the funds to expand its go-to-market teams, scale engineering, and accelerate its proprietary operating system, Trase Origin. It has grown to 55 employees and deployed agents at Duke University Health System.TechnicalAgentic AI startup raises $107M for regulated industry automationNorthern Virginia AI startup Trase raised $107 million in seed funding, led by ARCH Venture Partners with participation from Red Cell Partners, to develop AI agents for highly-regulated industries including healthcare. The company provides automation agents for sectors with privacy and security concerns, counting Duke University Health System and the US Navy among its customers, and plans to double its current 55-person headcount. The funding will support expansion of go-to-market operations and continued development of its HIPAA and SOC2-compliant platform, Trase Origin.TechStartupsVenture Capital & Startup Funding Roundup, June 25, 2026On June 25, 2026, venture capital focused on AI infrastructure, reliability, and regulated workflow automation, with major rounds including Alan's €480M Series G and Runpod's $100M Series A. Investors backed companies solving compute bottlenecks, hallucinations, and healthcare operations, signaling a shift toward AI's operating layer.Washington TechnologyDOD excels at prototyping. Getting to production is another story.At the Defense One Tech Summit, panelists said the DOD excels at prototyping but struggles to move innovations into production. They cited acquisition reform and additional funding as positive signs, but noted barriers like compliance and lack of data on contract conversions.